Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emer O'Connell

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
BMC Cancer|August 8, 2018
RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer - the S.U.R.G.U.V.A.N.T. trialH Paul Redmond, Peter M Neary, Marcel Jinih, et al.
Journal of Surgical Oncology|November 16, 2019
Mucinous adenocarcinoma of the colon and rectum: A genomic analysisIan S Reynolds, Emer O'Connell, Michael Fichtner, et al.
The Pharmacogenomics Journal|December 11, 2019
Mucinous adenocarcinoma is a pharmacogenomically distinct subtype of colorectal cancerIan S Reynolds, Emer O'Connell, Michael Fichtner, et al.
Journal of Public Health (Oxford, England)|April 14, 2011
Where do young adults want opportunistic chlamydia screening services to be located?Ruairi Brugha, Myles Balfe, Isabelle Jeffares, et al.
Frontiers in Oncology|July 17, 2023
Corrigendum: Mucinous adenocarcinoma of the rectum: a whole genome sequencing studyIan S Reynolds, Valentina Thomas, Emer O'Connell, et al.
Frontiers in Oncology|September 28, 2020
Mucinous Adenocarcinoma of the Rectum: A Whole Genome Sequencing StudyIan S Reynolds, Valentina Thomas, Emer O'Connell, et al.
Sexually Transmitted Infections|January 4, 2012
The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in IrelandPaddy Gillespie, Ciaran O'Neill, Elisabeth Adams, et al.
Diseases of the Colon and Rectum|December 16, 2022
Multiplexed Immunofluorescence Imaging Reveals an Immune-Rich Tumor Microenvironment in Mucinous Rectal Cancer Characterized by Increased Lymphocyte Infiltration and Enhanced Programmed Cell Death Protein 1 ExpressionWilliam P Duggan, Batuhan Kisakol, Emer O'Connell, et al.
Diseases of the Colon and Rectum|May 6, 2021
An Insight Into the Driver Mutations and Molecular Mechanisms Underlying Mucinous Adenocarcinoma of the RectumIan S Reynolds, Emer O'Connell, Michael Fichtner, et al.
Frontiers in Oncology|August 1, 2022
Apoptotic and Necroptotic Mediators are Differentially Expressed in Mucinous and Non-Mucinous Colorectal CancerEmer O'Connell, Ian S Reynolds, Andreas U Lindner, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
BMC Cancer|August 8, 2018
RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer - the S.U.R.G.U.V.A.N.T. trialH Paul Redmond, Peter M Neary, Marcel Jinih, et al.
Journal of Surgical Oncology|November 16, 2019
Mucinous adenocarcinoma of the colon and rectum: A genomic analysisIan S Reynolds, Emer O'Connell, Michael Fichtner, et al.
The Pharmacogenomics Journal|December 11, 2019
Mucinous adenocarcinoma is a pharmacogenomically distinct subtype of colorectal cancerIan S Reynolds, Emer O'Connell, Michael Fichtner, et al.
Journal of Public Health (Oxford, England)|April 14, 2011
Where do young adults want opportunistic chlamydia screening services to be located?Ruairi Brugha, Myles Balfe, Isabelle Jeffares, et al.
Frontiers in Oncology|July 17, 2023
Corrigendum: Mucinous adenocarcinoma of the rectum: a whole genome sequencing studyIan S Reynolds, Valentina Thomas, Emer O'Connell, et al.
Frontiers in Oncology|September 28, 2020
Mucinous Adenocarcinoma of the Rectum: A Whole Genome Sequencing StudyIan S Reynolds, Valentina Thomas, Emer O'Connell, et al.
Sexually Transmitted Infections|January 4, 2012
The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in IrelandPaddy Gillespie, Ciaran O'Neill, Elisabeth Adams, et al.
Diseases of the Colon and Rectum|December 16, 2022
Multiplexed Immunofluorescence Imaging Reveals an Immune-Rich Tumor Microenvironment in Mucinous Rectal Cancer Characterized by Increased Lymphocyte Infiltration and Enhanced Programmed Cell Death Protein 1 ExpressionWilliam P Duggan, Batuhan Kisakol, Emer O'Connell, et al.
Diseases of the Colon and Rectum|May 6, 2021
An Insight Into the Driver Mutations and Molecular Mechanisms Underlying Mucinous Adenocarcinoma of the RectumIan S Reynolds, Emer O'Connell, Michael Fichtner, et al.
Frontiers in Oncology|August 1, 2022
Apoptotic and Necroptotic Mediators are Differentially Expressed in Mucinous and Non-Mucinous Colorectal CancerEmer O'Connell, Ian S Reynolds, Andreas U Lindner, et al.
Pageof 4